Evidence map›Paper›PMID 41322279›Full record

ArticleJournal of pain research2025

Modulatory Effects of "Minor" Cannabinoids in an in vitro Model of Neuronal Hypersensitivity.

Uma Anand, Praveen Anand, Mikael H Sodergren

Abstract read
In one paragraph

Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Uma AnandDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0HS, UK.ORCID 0000-0002-3704-4600
Praveen AnandDepartment of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0HS, UK.
Mikael H SodergrenDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0HS, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Effective treatment for neuropathic pain remains an unmet clinical need. The therapeutic benefits of the Cannabis plant are well known, especially for pain relief. Here, we have assessed ten "minor" cannabinoids for their analgesic effects in an established model of neuronal hypersensitivity, a key mechanism which underlies neuropathic pain. Methods: Adult rat DRG neurons were cultured in medium containing 100 ng/mL nerve growth factor (NGF) and 50 ng/mL glial cell-line derived neurotrophic factor (GDNF) for 48 hours to sensitize the neurons. Ca Results: Control neurons (nociceptors) showed robust responses of Ca Conclusion: All the cannabinoids tested here inhibited TRPV1 signalling. CBC targeted K

Indexed as

analgesiacannabinoidschronic painsensory neuronstertiapin Q

Identifiers

PMID41322279
PMCPMC12661962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.